Increased Binding of Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinsons Disease Brain

This study demonstrates that the PET imaging probe [18F]nifene reveals significantly increased binding to α4β2* nicotinic acetylcholine receptors in the hippocampus and subiculum of postmortem Parkinson's disease brains compared to cognitively normal controls, suggesting its potential diagnostic value for detecting non-motor symptoms in Parkinson's disease.

Mukherjee, J., Karim, F., Ngo, A. + 3 more2026-04-08🧠 neuroscience

Transcriptional profiling of extraocular motor neurons reveals sim1a as a candidate strabismus-related gene

Using transcriptomic profiling and CRISPR/Cas9 mutagenesis in larval zebrafish, this study identifies *sim1a* as a candidate gene for strabismus that impairs eye movement via vestibulo-ocular reflex dysfunction without affecting motor neuron numbers, while establishing a pipeline for discovering genes underlying ocular motor diseases.

Gershowitz, E., Hamling, K. R., Rosti, B. + 6 more2026-04-08🧠 neuroscience

mPFC axons drive cognitive control enhancement during striatal stimulation

This study demonstrates that high-frequency optogenetic stimulation of medial prefrontal cortex (mPFC) axons, rather than local mid-striatal neurons, is the primary driver of cognitive control enhancement during ventral striatal deep brain stimulation, revealing a neuroplastic mechanism underlying the therapeutic effects of this treatment.

Sachse, E. M., Dastin-van Rijn, E. M., Bennek, J. P. + 6 more2026-04-08🧠 neuroscience

BDNF and glucocorticoids modulate neuroplasticity via direct interaction between TRKB and glucocorticoid receptors

This study reveals that glucocorticoids modulate neuronal plasticity by promoting TRKB dimerization and signaling through a physical interaction between glucocorticoid receptors and TRKB, a mechanism that operates independently of direct glucocorticoid binding to TRKB and involves the transmembrane domain.

Brunello, C. A., Gil Ortiz, M., Pastor Munoz, P. + 8 more2026-04-08🧠 neuroscience

Linguistic and Acoustic Biomarkers from Simulated Speech Reveal Early Cognitive Impairment Patterns in Alzheimers Disease

This study presents FMN, a simulated speech dataset and explainable machine learning framework that successfully models linguistic and acoustic biomarkers to distinguish between healthy controls, mild cognitive impairment, and Alzheimer's disease with high accuracy, offering a scalable pipeline for future cognitive screening research.

Debnath, A., Sarkar, S.2026-04-08🧠 neuroscience

Brain predictive models of cognition fail to generalize across ethnicities: Modality-dependent bias in MRI-based prediction

Using Adolescent Brain Cognitive Development data, this study reveals that MRI-based cognitive prediction models exhibit pervasive, modality-dependent ethnic bias that favors White participants, but demonstrates that balancing training samples and prioritizing task-based fMRI phenotypes can significantly improve fairness without sacrificing accuracy.

Lal Khakpoor, F., van der Vliet, W., Deng, J. + 1 more2026-04-07🧠 neuroscience

Instability of Alpha Oscillatory States in Autism and Familial Liability: Evidence from Burst-Resolved High-Density Electroencephalography (EEG)

This study reveals that atypical alpha oscillatory activity in autistic children and their siblings is primarily characterized by reduced temporal stability and density of alpha bursts rather than diminished oscillatory amplitude, suggesting that the instability of these rhythms serves as a neural marker for altered cortical excitability and sensory regulation.

Vanneau, T., Brittenham, C., Darrell, M. + 3 more2026-04-07🧠 neuroscience

WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease

This study identifies WDR44 as a critical adaptor protein that drives the initiation of de novo α-synuclein aggregation at the lysosomal membrane in Parkinson's disease, thereby compromising lysosomal function and promoting neuronal dysfunction, which positions the WDR44–α-synuclein interaction as a promising therapeutic target for early intervention.

Teixeira, M., Sheta, R., Berard, M. + 21 more2026-04-07🧠 neuroscience